Advances in the Use of Anti-inflammatory Agents to Manage Chemotherapy-induced Oral and Gastrointestinal Mucositis.

Mucositis is a side effect associated with the use of chemotherapy, and has a significant impact on the quality of life. Mucositis, by definition, refers to the inflammation of the mucosa and occurs throughout the alimentary tract from the mouth to anus. Nuclear Factor kappa B (NFκB) encompasses a family of transcription factors, which upregulate pro-inflammatory cytokines. These are recognized as key targets in developing therapeutic interventions for chemotherapy-induced mucositis, and cyclooxygenase (COX)-2 inhibition may also be beneficial in reducing the severity and duration. This review focuses on the pathobiology of chemotherapy-induced oral and gastrointestinal mucositis and recent research examining the role of agents with anti-inflammatory activity in treatment and prevention of the condition. We consider agents in clinical use as well as some others under current investigation including plant-derived and other natural medicines.

• Publication year

  2018

• Venue

  Current pharmaceutical design

• Publication date

  2018-07-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.2174/1381612824666180409093918PMID 29629657
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Efficacy of prophylactic gabapentin in managing oral mucositis pain in patients undergoing non-surgical management of head and neck tumors

  2025cites this paper
• Effects of Aromatherapy on Chemotherapy-Induced Gastrointestinal Toxicity in Patients With Cancer: Protocol for a Systematic Review and Meta-Analysis of Randomized Controlled Trials

  2025cites this paper
• Effect of honey-ginger mouthwash on oral mucositis in patients undergoing chemotherapy

  2025cites this paper
• Chlorogenic acid attenuates 5-fluorouracil-induced intestinal mucositis in mice through SIRT1 signaling-mediated oxidative stress and inflammatory pathways.

  2025cites this paper
• Progress in the study of the correlation between sepsis and intestinal microecology

  2024cites this paper
• The Effect of Gastrointestinal Mucositis Care Training Given to Pediatric Leukemic Patients and Caregivers on Mucosal Barrier Injury.

  2024cites this paper
• Intravenous immunoglobulin ameliorates doxorubicin-induced intestinal mucositis by inhibiting the Syk/PI3K/Akt axis and ferroptosis

  2024cites this paper
• Effectiveness of Glutamine Oral Care in Reducing Oral Mucositis and Improving Oral Health After Neurosurgery: A Randomized Controlled Trial with Microbiome Analysis

  2024cites this paper
• Whey-based diet containing medium chain triglycerides modulates the gut microbiota and protects the intestinal mucosa from chemotherapy while maintaining therapy efficacy

  2023cites this paper
• Synergistic Strategies for Gastrointestinal Cancer Care: Unveiling the Benefits of Immunonutrition and Microbiota Modulation

  2023cites this paper
• Study of prevalence and risk factors of chemotherapy-induced mucositis in gastrointestinal cancer using machine learning models

  2023cites this paper
• The efficacy of honey or olive oil on the severity of oral mucositis and pain compared to placebo (standard care) in children with leukemia receiving intensive chemotherapy: A randomized controlled trial (RCT).

  2023cites this paper
• Chemotherapy-associated oral microbiome changes in breast cancer patients

  2022cites this paper
• The protective effects of HIF-1α activation on sepsis induced intestinal mucosal barrier injury in rats model of sepsis

  2022cites this paper
• Anti-inflammatory mouthwashes for the prevention of oral mucositis in cancer therapy: an integrative review and meta-analysis

  2022cites this paper
• Management of oral mucositis in children.

  2022cites this paper
• Effects of an elemental diet to reduce adverse events in patients with esophageal cancer receiving docetaxel/cisplatin/5-fluorouracil: a phase III randomized controlled trial—EPOC 2 (JFMC49-1601-C5)

  2021cites this paper
• Eosinophil plays a crucial role in intestinal mucositis induced by antineoplastic chemotherapy

  2021cites this paper
• Validity and reliability of the Persian version of the oropharyngeal Mucositis quality of life scale

  2021cites this paper
• Probiotics and Cancer

  2021cites this paper
• Assessing the topical application efficiency of two biological agents in managing chemotherapy-induced oral mucositis in children: A randomized clinical trial.

  2021cites this paper
• The Efficacy of Heat-Clearing (Qingre) and Detoxifying (Jiedu) Traditional Chinese Medicine Gargle for Chemotherapy-Induced Oral Mucositis: A Systematic Review and Meta-Analysis

  2021cites this paper
• Cognitive complications of cancer and cancer-related treatments – Novel paradigms

  2021cites this paper
• Efficacy of gabapentin mouthwash in managing oral mucositis pain in patients undergoing chemotherapy: a prospective, randomised, double-blind, controlled clinical trial

  2020cites this paper
• Anti-inflammatory and antioxidant activity of hydroethanolic extract of Spondias mombin leaf in an oral mucositis experimental model.

  2020cites this paper
• The MASCC/ISOO mucositis guidelines 2019: the second set of articles and future directions

  2020cites this paper
• Impact of oral mucositis on quality of life in patients undergoing oncological treatment: a systematic review

  2020cites this paper
• Gastrointestinal peptides in children before and after hematopoietic stem cell transplantation

  2020cites this paper
• Changes in the prosthetic base in oncological patients – review of literature

  2020cites this paper
• Prevention and treatment of oral mucositis among cancer patients in the hematology-oncology setting: a best practice implementation project.

  2020cites this paper
• Functional metabolomics reveal the role of AHR/GPR35 mediated kynurenic acid gradient sensing in chemotherapy-induced intestinal damage

  2020cites this paper
• Altered expression of amino acid transporter LATs of intestinal cells in 5-fluorouracil-induced intestinal mucosal inflammation

  2020cites this paper
• Complications associated with oncological therapy - how to minimize?

  2020cites this paper
• Randomized double-blind, placebo-controlled trial evaluating oral glutamine on radiation-induced oral mucositis and dermatitis in head and neck cancer patients

  2019cites this paper
• Amifostine reduces inflammation and protects against 5-fluorouracil-induced oral mucositis and hyposalivation

  2019cites this paper
• Therapeutic Effect of GGsTop, Selective Gamma-glutamyl Transpeptidase Inhibitor, on a Mouse Model of 5-Fluorouracil-induced Oral Mucositis

  2019cites this paper
• Rebamipide-containing Film Using Chitosan and HPMC for Oral Mucositis Induced by Cancer Chemotherapy

  2019cites this paper
• A novel formulation for radiotherapy-induced oral mucositis: Triamcinolone acetonide mucoadhesive film

  2019cites this paper
• Comparison of Antimicrobial Effects of Matrica Herbal Mouthwash and 0.2% Chlorhexidine on the Growth of Streptococcus Mutans, Actinomyces Viscosus, and Enterobacter Cloacae: A Short Report

  2019cites this paper
• Development of the MASCC/ISOO clinical practice guidelines for mucositis: an overview of the methods.

  2019cites this paper
• Gliclazide Prevents 5-FU-Induced Oral Mucositis by Reducing Oxidative Stress, Inflammation, and P-Selectin Adhesion Molecules

  2019cites this paper
• Natural Product Interventions for Chemotherapy and Radiotherapy-Induced Side Effects

  2018cites this paper
• Peroxisome proliferator activated receptor‐gamma stimulation for prevention of 5‐fluorouracil‐induced oral mucositis in mice

  2018cites this paper
• Comparison of triamcinolone acetonide mucoadhesive film with licorice mucoadhesive film on radiotherapy‐induced oral mucositis: A randomized double‐blinded clinical trial

  2017cites this paper
• Prevention and care of chemotherapy-induced gastrointestinal mucositis

  2017cites this paper
• Absorption of Bupivacaine after Administration of a Lozenge as Topical Treatment for Pain from Oral Mucositis

  2017cites this paper
• The Prevalence and Investigation of Risk Factors of Oral Mucositis in a Pediatric Oncology Inpatient Population; a Prospective Study

  2017cites this paper
• Efficacy of chlorhexidine for the prevention and treatment of oral mucositis in cancer patients: a systematic review with meta‐analyses

  2017cites this paper
• Use of sodium hyaluronate and synthetic amino acid precursors of collagen for the symptomatic treatment of mucositis in patients undergoing haematopoietic stem cell transplants.

  2016cites this paper
• A novel lozenge containing bupivacaine as topical alleviation of oral mucositis pain in patients with head and neck cancer: a pilot study

  2016cites this paper
• Chemotherapy-Induced Constipation and Diarrhea: Pathophysiology, Current and Emerging Treatments

  2016cites this paper
• Gastrointestinal tract as a side-effect target of medications.

  2016cites this paper
• Pharmacological correction of various morphological forms of oral mucositis in patients with leukemia

  year unknowncites this paper